ImmunXperts, a Q² Solutions Company, has a unique knowledge in building custom assays that can be useful to cell therapy companies
Cell Therapy products offer the potential of curing diseases that today have only palliative treatments in the best case.
The ability to produce large quantities of biological products with predictable quality and quantifiable potency is becoming critical. And this is also a regulatory requirement for phase III and commercialization.
ImmunXperts has the capacity to develop custom in vitro assays to screen immunomodulatory properties of Stem Cells, selecting the potency markers that make the most sense for each product.
For questions or to request a quotation, please contact us.